Author:
Peng Zhengjun,Zhang Wenyu,Hong Hong,Liu Lu
Abstract
Abstract
Background
Periapical lesions are characterized by periapical inflammation and damage to periapical tissues and eventually lead to bone resorption and even tooth loss. H2O2 is widely used in root canal therapy for patients with periapical inflammation. Luteolin possesses high anti-inflammatory, antioxidant, and anticancer potential. However, the underlying mechanism of the efficacy of H2O2 and luteolin on oxidative stress and inflammatory tissue has not been previously addressed. We aimed to investigate the anti-inflammatory and antioxidative effects of luteolin on H2O2-induced cellular oxidative inflammation.
Methods
After human osteoblasts (hFOB1.19) were treated with lipopolysaccharide (LPS), luteolin, or H2O2, cell proliferation was analysed by using a cell counting kit-8 (CCK-8), cell apoptosis was measured by using flow cytometry, the production of reactive oxygen species (ROS) was evaluated by using an oxidation-sensitive probe DCFH-DA ROS assay kit, and the expression of genes and proteins was detected by using reverse transcription quantitative polymerase chain reaction (RT‒qPCR), Western blotting, and enzyme-linked immunosorbent assay (ELISA).
Results
We demonstrated that inflammation is closely related to oxidative stress and that the oxidative stress level in the inflammatory environment is increased. Luteolin inhibited the H2O2-induced increase in the expression of interleukin-6 (IL-6), interleukin-8 (IL-8) and tumour necrosis factor α (TNF-α) and significantly repressed the H2O2-induced increase in ROS, as well as markedly strengthened superoxide dismutase (SOD) activity in hFOB1.19 cells. Moreover, we detected that luteolin may inhibit H2O2-induced hFOB1.19 cell injury by suppressing the NF-κB pathway.
Conclusion
We elucidated that luteolin protected human osteoblasts (hFOB1.19) from H2O2-induced cell injury and inhibited the production of proinflammatory cytokines by suppressing the NF-κB signalling pathway. Our findings provide a potential drug for treating H2O2-induced periodontitis and cell injury.
Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference59 articles.
1. Braz-Silva PH, Bergamini ML, Mardegan AP, De Rosa CS, Hasseus B, Jonasson P. Inflammatory profile of chronic apical periodontitis: a literature review. Acta Odontol Scand. 2019;77(3):173–80.
2. Karteva T, Manchorova-Veleva N. The role of the immune response in chronic marginal and apical periodontitis. Folia Medica. 2020;62(2):238–43.
3. Dal-Fabbro R, Marques-de-Almeida M, Cosme-Silva L, Ervolino E, Cintra LTA, Gomes-Filho JE. Chronic alcohol consumption increases inflammation and osteoclastogenesis in apical periodontitis. Int Endod J. 2019;52(3):329–36.
4. Li X, Han X, Yu W, Chen X, Wu Y, Lu L. Correlation between transforming growth factor-β and periapical lesions in patients with chronic apical periodontitis. J Healthc Eng. 2022;2022:2173434.
5. Barnes PJ. Oxidative stress-based therapeutics in COPD. Redox Biol. 2020;33:101544.